1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Small Bowel Cancer: new trials by email Literature Review of Small Bowel Cancer trials Research Report on Small Bowel Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies KRAS TCR-Transduced PBL, Aldesleukin, Fludarabine - Gastrointestinal Carcinoma, Pancreatic Cancer | Phase 2 | Withdrawn | National Cancer Institute (NCI) | 2025-09-09 | 2025-09-11 |
Cholangiocarcinoma (1) · Colorectal Neoplasms (1) · Duodenal Neoplasms (1) · Liver Neoplasms (1) · Neoplasms (1) · Pancreatic Neoplasms (1)
Adenocarcinoma (1) · Carcinoma (1) · Colonic Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Duodenal Diseases (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Liver Diseases (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1)
Cyclophosphamide (1) · aldesleukin (1) · fludarabine (1)
National Cancer Institute (NCI) (1)
United States (1)